Literature DB >> 29784124

Caval Thrombus Management: The Data, Where We Are, and How It Is Done.

Brittany Harrison1, Frank Hao2, Nii Koney2, Justin McWilliams2, John M Moriarty2.   

Abstract

Thromboses of the superior and inferior vena cava, either isolated or associated with distal deep venous thrombosis, are uncommon, but confer potentially serious morbidity and mortality. Incidence is increasing, especially with the prominence of intravascular devices. The range of treatment options is also expanding to include medical management, surgery, and endovascular techniques which are now frequently considered first line therapy due to lower reintervention rates and decreased periprocedural morbidity. Currently, there are no official guidelines for screening or treatment. This article reviews the etiology, diagnosis, and management of caval thromboses, including equipment, procedural steps, outcomes, and complications, particularly with regard to endovascular techniques, such as catheter-directed thrombolysis, pharmacomechanical catheter-directed thrombolysis, angioplasty, and stenting.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  catheter-directed thrombolysis; caval thrombus; endovascular therapy; inferior vena cava thrombus; pharmacomechanical catheter-directed thrombolysis; superior vena cava thrombus

Mesh:

Substances:

Year:  2018        PMID: 29784124     DOI: 10.1053/j.tvir.2018.03.002

Source DB:  PubMed          Journal:  Tech Vasc Interv Radiol        ISSN: 1557-9808


  2 in total

Review 1.  Thrombophlebitis hiding under a KILT - case report on 40 years long-term follow-up of neonatal renal vein thrombosis.

Authors:  Stefan Lauener; Anne Bütikofer; Sandra Eigenheer; Robert Escher
Journal:  BMC Pediatr       Date:  2019-06-06       Impact factor: 2.125

2.  Catheter-directed thrombectomy with the JETi8 in the treatment of acute superior vena cava syndrome.

Authors:  Raffaella Emsley; Claude Haller; Laure Arts
Journal:  J Vasc Surg Cases Innov Tech       Date:  2022-08-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.